FWIW, I dont think consolidation will be of any benefit here. The main game price wise, is the USA and that is 600:1 ADR.
Unless we get some pumpers with a X or other social following then small biotech investing is kaput in AUS. Social traction is far more important to price than fundamentals these days.
imo
Also, not too sure if the IMU crew are loving the upcoming consolidation
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)